Dr. Guidon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
165 Cambridge St
Ste 820
Boston, MA 02114Phone+1 855-644-6387Fax+1 617-726-2019
Education & Training
Duke University HospitalFellowship, Neuromuscular Medicine (Neurology), 2012 - 2013- Duke University HospitalFellowship, Neuromuscular Medicine (Neurology), 2011 - 2012
- Duke University HospitalResidency, Neurology, 2008 - 2011
- Duke University HospitalInternship, Internal Medicine, 2007 - 2008
University of Rochester School of Medicine and DentistryClass of 2007
Certifications & Licensure
ME State Medical License Current
MA State Medical License 2013 - 2025
NC State Medical License 2007 - 2014- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
- American Board of Electrodiagnostic Medicine (ABEM)
Publications & Presentations
PubMed
- Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States.Jennifer Morganroth, Leah Zuroff, Amanda C Guidon, Grant T Liu, Shawn J Bird
Neurology. Clinical Practice. 2024-10-01 - 1 citationsPeripheral nervous system immune-related adverse events due to checkpoint inhibition.Meabh O'Hare, Amanda C Guidon
Nature Reviews. Neurology. 2024-09-01 - 16 citationsNeurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes.Antonio Farina, Macarena Villagrán-García, Alberto Vogrig, Anastasia Zekeridou, Sergio Muñiz-Castrillo
The Lancet. Neurology. 2024-01-01
Press Mentions
Myasthenia Gravis: Where Does Traditional Therapy Fit In?November 4th, 2024
“Chemical Plasmapheresis” Drug for Myasthenia Gravis Is Safe, Lowers Antibodies, and Produces Hints of Efficacy in Phase 2 TrialJuly 11th, 2019
Myasthenia Gravis: Framingham Resident Lives with Rare DiseaseJune 24th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
